Piomic

company

About

Advanced wound care, made personal.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
Fr7.50M
Industries
Health Care,Medical,Medical Device,Therapeutics
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

There are about 50 million reported cases of patients suffering from hard-to-heal wounds, which has created a severe cost burden on global healthcare systems.

The COMS® One Therapy System is a portable, hand-held device which incorporates the technologies for optical and magnetic stimulation, intended to promote wound healing in chronic leg and foot ulcers.

The pivotal clinical study showed that the treatment is safe, leads to accelerated wound closure, overall reduced pain and increased quality of life.
The easy-to-use, single button operated device integrates smoothly into the patient’s healing journey with usage in stationary and ambulant facilities but also in patient’s home.

By developing a therapy which is safe and effective we hope to set a better future for patients in need.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
Fr10.20M
Piomic has raised a total of Fr10.20M in funding over 2 rounds. Their latest funding was raised on Jul 28, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 28, 2022 Series A Fr7.50M 2 Detail
Mar 29, 2022 Grant Fr2.70M 1 European Innovation Council Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Piomic is funded by 3 investors. European Innovation Council and Verve Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant
Verve Ventures Series A
NEST pension fund Series A